The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing
Open accessAbstract
Lymphoid Enhancer Factor-1 (LEF-1) is a member of a family of transcription factors that function as downstream mediators of the Wnt signal transduction pathway. In the absence of Wnt signals, specific LEF/TCF isoforms repress rather than activate gene targets through recruitment of the co-repressor CtBP. Characterization of the full-length human LEF-1 gene locus and its complete set of mRNA products shows that this family member exists as a unique set of alternatively spliced isoforms; none are homologous to TCF-1E/TCF-4E. Therefore LEF-1 is distinct from its TCF family members in that it cannot engage in activities specific to this isoform such as recruitment of the co-repressor CtBP. Expression of alternatively spliced LEF-1 isoforms are driven by a promoter that is highly active in lymphocyte cell lines. Transcription initiates within a TATA-less core promoter region that contains consensus binding sites for Sp1, an E box, an Initiator element and a LEF/TCF binding site, all juxtaposed to the start sites of transcription. The promoter is most active in a B lymphocyte cell line (Raji) in which the endogenous LEF-1 gene is silent, suggesting that the promoter region is actively repressed by a silencing mechanism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
HeLa cells contain low levels of endogenous LEF-1/TCF.
“HeLa cells, which contain low levels of endogenous LEF-1/TCF (10).”
From Regulation of Lymphoid Enhancer Factor 1/T-Cell Factor by Mitogen-Activated Protein Kinase-Related Nemo-Like Kinase-Dependent Phosphorylation in Wnt/β-Catenin Signaling (2003) · cites this paper as [10]
The Results (page not provided) describe HeLa cells as not expressing LEF-1, supporting low endogenous LEF-1 relative to LEF-1-expressing Jurkat cells. The passage does not establish the level of endogenous TCF in HeLa cells. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 40
- [1]Brown J. and Moon,R. (1998) Curr. Opin. Cell Biol., 10, 182–187. [DOI] [PubMed] [Google Scholar]
- [2]Brannon M., Brown,J.D., Bates,R., Kimelman,D. and Moon,R.T. (1999) Development, 126, 3159–3170. [DOI] [PubMed] [Google Scholar]
- [3]Roose J., Molenaar,M., Peterson,J., Hurenkamp,J., Brantjes,H., Moerer,P., van de Wetering,M., Destree,O. and Clevers,H. (1998) Nature, 395, 608–612. [DOI] [PubMed] [Google Scholar]
- [4]Cavallo R.A., Cox,R.T., Moline,M.M., Roose,J., Polevoy,G.A., Clevers,H., Peifer,M. and Bejsovec,A. (1998) Nature, 395, 604–608. [DOI] [PubMed] [Google Scholar]
- [5]Oosterwegel M., van de Wetering,M., Timmerman,J., Kruisbeek,A., Destree,O., Meijlink,F. and Clevers,H. (1993) Development, 118, 439–448. [DOI] [PubMed] [Google Scholar]
- [6]Korinek V., Barker,N., Willert,K., Molenaar,M., Roose,J., Wagenaar,G., Markman,M., Lamers,W., Destree,O. and Clevers,H. (1998) Mol. Cell. Biol., 18, 1248–1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7]Kratochwil K., Dull,M., Farinas,I., Galceran,J. and Grosschedl,R. (1996) Genes Dev., 10, 1382–1394. [DOI] [PubMed] [Google Scholar]
- [8]van Genderen C., Okamura,R., Farinas,I., Quo,R., Parslow,T., Bruhn,L. and Grosschedl,R. (1994) Genes Dev., 8, 2691–2703. [DOI] [PubMed] [Google Scholar]
- [9]Galceran J., Farinas,I., Depew,M.J., Clevers,H. and Grosschedl,R. (1999) Genes Dev., 13, 709–717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10]Verbeek S., Izon,D., Hofhuis,F., Robanus-Maandag,E., te Riele,H., van de Wetering,M., Oosterwegel,M., Wilson,A., MacDonald,H.R. and Clevers,H. (1995) Nature, 374, 70–74. [DOI] [PubMed] [Google Scholar]
- [11]Korinek V., Barker,N., Moerer,P., van Donselaar,E., Huls,G., Peters,P.J. and Clevers,H. (1998) Nature Genet., 19, 379–383. [DOI] [PubMed] [Google Scholar]
- [12]Okamura R., Sigvardsson,M., Galceran,J., Verbeek,S., Clevers,H. and Grosschedl,R. (1998) Immunity, 8, 11–20. [DOI] [PubMed] [Google Scholar]
- [13]Waterman M.L., Fischer,W.H. and Jones,K.A. (1991) Genes Dev., 5, 656–669. [DOI] [PubMed] [Google Scholar]
- [14]Travis A., Amsterdam,A., Belanger,C. and Grosschedl,R. (1991) Genes Dev., 5, 880–894. [DOI] [PubMed] [Google Scholar]
- [15]van de Wetering M., Oosterwegel,M., Dooijes,D. and Clevers,H. (1991) EMBO J., 10, 123–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16]Zhou P., Byrne,C., Jacobs,J. and Fuchs,E. (1995) Genes Dev., 9, 700–713. [DOI] [PubMed] [Google Scholar]
- [17]Oosterwegel M., van de Wetering,M. and Clevers,H. (1993) Thymus, 22, 67–81. [PubMed] [Google Scholar]
- [18]Porfiri E., Rubinfeld,B., Albert,I., Hovanes,K., Waterman,M. and Polakis,P. (1997) Oncogene, 15, 2833–2839. [DOI] [PubMed] [Google Scholar]
- [19]Rubinfeld B., Robbins,P., El-Gamil,M., Albert,I., Porfiri,E. and Polakis,P. (1997) Science, 275, 1790–1792. [DOI] [PubMed] [Google Scholar]
- [20]Church D.M., Yang,J., Bocian,M., Shiang,R. and Wasmuth,J.J. (1997) Genome Res., 7, 787–801. [DOI] [PubMed] [Google Scholar]
- [21]Jones K.A., Luciw,P.A. and Duchange,N. (1988) Genes Dev., 2, 1101–1114. [DOI] [PubMed] [Google Scholar]
- [22]Waterman M. and Jones,K. (1990) New Biologist, 2, 621–636. [PubMed] [Google Scholar]
- [23]van de Wetering M., Cavallo,R., Dooijes,D., van Beest,M., van Es,J., Loureiro,J., Ypma,A., Hursh,D., Jones,T., Bejsovec,A., Peifer,M., Mortin,M. and Clevers,H. (1997) Cell, 88, 789–799. [DOI] [PubMed] [Google Scholar]
- [24]Van de Wetering M., Castrop,J., Korinek,V. and Clevers,H. (1996) Mol. Cell. Biol., 16, 745–752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25]Lee Y.J., Swencki,B., Shoichet,S. and Shivdasani,R.A. (1999) J. Biol. Chem., 274, 1566–1572. [DOI] [PubMed] [Google Scholar]
- [26]Molenaar M., van de Wetering,M., Oosterwegel,M., Peterson-Maduro,J., Godsave,S., Korinek,V., Roose,J., Destree,O. and Clevers,H. (1996) Cell, 86, 391–399. [DOI] [PubMed] [Google Scholar]
- [27]Lin R., Thompson,S. and Priess,J. (1995) Cell, 83, 599–609. [DOI] [PubMed] [Google Scholar]
- [28]Dooijes D., van Beest,M., van de Wetering,M., Boulanger,G., Jones,T., Clevers,H. and Mortin,M.A. (1998) Mol. Gen. Genet., 258, 45–52. [DOI] [PubMed] [Google Scholar]
- [29]Smale S.T., Jain,A., Kaufmann,J., Emami,K.H., Lo,K. and Garraway,I.P. (1998) Cold Spring Harb. Symp. Quant. Biol., 63, 21–31. [DOI] [PubMed] [Google Scholar]
- [30]Bain G., Robanus Maandag,E.C., te Riele,H.P., Feeney,A.J., Sheehy,A., Schlissel,M., Shinton,S.A., Hardy,R.R. and Murre,C. (1997) Immunity, 6, 145–154. [DOI] [PubMed] [Google Scholar]
- [31]Murre C., McCaw,P.S., Vaessin,H., Caudy,M., Jan,L.Y., Jan,Y.N., Cabrera,C.V., Buskin,J.N., Hauschka,S.D., Lassar,A.B. et al. (1989) Cell, 58, 537–544. [DOI] [PubMed] [Google Scholar]
- [32]Soeller W.C., Oh,C.E. and Kornberg,T.B. (1993) Mol. Cell. Biol., 13, 7961–7970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33]Farkas G., Gausz,J., Galloni,M., Reuter,G., Gyurkovics,H. and Karch,F. (1994) Nature, 371, 806–808. [DOI] [PubMed] [Google Scholar]
- [34]Roose J., Huls,G., van Beest,M., Moerer,P., van der Horn,K., Goldschmeding,R., Logtenberg,T. and Clevers,H. (1999) Science, 285, 1923–1926. [DOI] [PubMed] [Google Scholar]
- [35]Giese K., Amsterdam,A. and Grosschedl,R. (1991) Genes Dev., 5, 2567–2578. [DOI] [PubMed] [Google Scholar]
- [36]van de Wetering M. and Clevers,H. (1992) EMBO J., 11, 3039–3044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37]Nishita M., Hashimoto,M.K., Ogata,S., Laurent,M.N., Ueno,N., Shibuya,H. and Cho,K.W.Y. (2000) Nature, 403, 781–783. [DOI] [PubMed] [Google Scholar]
- [38]Sheridan P.L., Sheline,C.T., Cannon,K., Voz,M.L., Pazin,M.J., Kadonaga,J.T. and Jones,K.A. (1995) Genes Dev., 9, 2090–2104. [DOI] [PubMed] [Google Scholar]
- [39]Riese J., Yu,X., Munnerlyn,A., Eresh,S., Hsu,S.C., Grosschedl,R. and Bienz,M. (1997) Cell, 88, 777–787. [DOI] [PubMed] [Google Scholar]
- [40]Carlsson P., Waterman,M. and Jones,K. (1993) Genes Dev., 7, 2418–2430. [DOI] [PubMed] [Google Scholar]
Cited by
Sorted by citations
Ishitani, T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1379-1389.2003 · Cited by 212 · see citing works
WNT Signaling and Lymphocyte Development
van de Wetering, M., de Lau, W., & Clevers, H. (2002) · Cell · doi:10.1016/s0092-8674(02)00709-2 · Cited by 139 · see citing works
Kuwahara, A., Sakai, H., Xu, Y., Itoh, Y., Hirabayashi, Y., & Gotoh, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094408 · Cited by 66 · see citing works
Wisniewska, M. B., Misztal, K., Michowski, W., Szczot, M., Purta, E., Lesniak, W., Klejman, M. E., Dabrowski, M., Filipkowski, R. K., Nagalski, A., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1425-09.2010 · Cited by 64 · see citing works
Dufour, W., Alawbathani, S., Jourdain, A.-S., Asif, M., Baujat, G., Becker, C., Budde, B., Gallacher, L., Georgomanolis, T., Ghoumid, J., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.04.022 · Cited by 14 · see citing works
- Authors
- Hovanes, K., Li, T. W. H., & Waterman, M. L.
- Affiliations
- University of California, Irvine (US)
- ORCID
- Waterman, M. L.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-05-01
- Volume
- 28
- Issue
- 9
- Pages
- 1994-2003
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC103301
- OpenAlex
- W2139146322
- Cited by
- 101
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 5 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 4
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Nucleic Acids Research (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- LEF1, lymphoid enhancer factor 1, Wnt signaling, transcription factors, alternative splicing, protein isoforms, promoter, lymphocytes, B cells, TATA-less promoter, Sp1 binding site, E-box, initiator element, gene silencing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Exons, Gene Expression Regulation, Genes, HeLa Cells, Humans, Introns, Luciferases, Lymphocytes, Male, Molecular Sequence Data, Promoter Regions, Genetic, Protein Binding, Recombinant Fusion Proteins, Transcription Factors, Transfection, Tumor Cells, Cultured, Sequence Alignment, PC12 Cells, Conserved Sequence, Sequence Deletion, Sequence Homology, Amino Acid, Alternative Splicing, Sequence Analysis, DNA, Jurkat Cells, COS Cells, Protein Isoforms, Rats, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review